Welcome and introduction (ID 6020)
Question 1: How should we manage oligometastatic disease? (ID 6021)
Question 2: What is the role of chemotherapy alongside hormonal treatments in mHSPC? (ID 6022)
Question 3: How do we choose treatment options for patients with mCRPC? (ID 6023)
